glp-1 insulin Receptor Agonists as Treatments for Type 2 Diabetes What is GLP-1 & Does
Description
doi: 10.1007/s10654-021-00757-1 23 De AngelisLMarfellaMASiniscalchiMMarinoLNappoFGiuglianoFet al
The ideas, opinions and suggestions contained on this website are not to be used as a substitute for medical advice, diagnosis or treatment from your doctor for any health condition or problem
What it means here: two similarly named, separately owned products that are easy to confuse
Furthermore, the risks of myocardial infarction (HR 0.91, 95% CI 0.840.98 with GLP-1RAs and HR 0.89, 95% CI 0.800.98 with SGLT2is) and cardiovascular death (HR 0.88, 95% CI 0.800.96 with GLP-1RAs and HR 0.84, 95% CI 0.750.94 with SGLT2is) were similarly reduced in both GLP-1RA and SGLT2i groups, while the risk of stroke was reduced only with GLP-1RAs (HR 0.86, 95% CI 0.770.97 with GLP-1RAs and HR 0.97, 95% CI 0.861.10 with SGLT2is)
Medication activity indicator Peps body-level indicator shows when your medication is most active in your system, helping you plan meals, workouts, and expectations around it
I like how you talked about the streetlight analogy
